News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2026|
Sales Effectiveness
Advertisement
|Articles|October 15, 2009

Listen to a preview of Drugs, Devices or Data - Which is Most Valuable? Webcast

Advertisement

Listen to a preview of Drugs, Devices or Data – Which is Most Valuable? Webcast

Download Adobe Flash PlayerRegister Free for the Webcast

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement
Technology

Related Content

Advertisement
Stock.adobe.com Hub Services

Asembia ASX26: Inizio Launches Next-Generation Hub Services

ByNicholas Jacobus
April 30th 2026
Kim Plesnarski, vice president, strategic market access and patient support, Syneos Health

Asembia's AXS26 Summit: Are Regulatory Policies Impacting Early-Stage Portfolio Planning?

ByNicholas Jacobus,Kim Plesnarski
April 29th 2026
Suresh Palliparambil

How RFID is Reshaping Health and Wellness Supply Chains: Q&A with Suresh Palliparambil

ByMike Hollan,Suresh Palliparambil
April 27th 2026
Sheeta Chawal

Scaling AI in Pharma Requires More Than Algorithms

BySheetal Chawla
April 21st 2026
Drug labeling is a distinct linguistic domain, and models not trained explicitly on it struggle with it. Credit: Stock.Adobe.com/GamePixel.

How AI Is Transforming Drug Labeling

ByPartha Anbil,Partha Khot ,Prashant Deshpande
April 16th 2026
Advertisement
Advertisement

Trending on PharmExec

1

Sanofi Officially Appoints Belén Garijo as Chief Executive Officer Following Shareholder Vote

2

Which Supply Chains are Most Exposed by Disruptions in The Strait of Hormuz?

3

Alternative Supply Chain Strategies Companies Should Prioritize

4

Using a Customer-Based Process to Synchronize Sales & Marketing Organizations in Pharma

5

Pharmaceutical Executive Daily: Sanofi Appoints Belén Garijo as CEO

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us